IVim Technology

IVim Technology FCF per Share

The Free Cash Flow per Share of IVim Technology (460470.KQ) as of Nov 4, 2026 is -444.91 KRW. In the previous year, Free Cash Flow per Share was -503.46 KRW — a change of -11.63% (higher).

FCF per Share

-444.91KRW

YoY

-11.63%

Last updated:

Free Cash Flow per Share of IVim Technology is 2025 -444.91 KRW. Free Cash Flow per Share of IVim Technology was 2024 -503.46 KRW. It decreases by -11.63% higher compared to the previous year.

The IVim Technology FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2021
-388.73 KRW
Jan 1, 2022
-301.02 KRW
Jan 1, 2023
-263.42 KRW
Jan 1, 2024
-503.46 KRW
Jan 1, 2025
-444.91 KRW
The IVim Technology FCF per Share history
YEARFCF per ShareYoY
-444.91KRW-11.63%
-503.46KRW+91.13%
-263.42KRW-12.49%
-301.02KRW-22.56%
-388.73KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IVim Technology Stock analysis

What does IVim Technology do? IVim Technology Inc generates revenue through the development, manufacture, and sale of biological microscopes utilizing in vivo live cell imaging platform technology. The company offers imaging accessories and provides cellular-level imaging acquisition services inside living bodies along with kinetic analysis services for injected drugs. Its primary customers are healthcare institutions requiring advanced imaging solutions for research and diagnostic purposes. The firm targets the health care equipment and supplies industry segment focused on in vivo cellular analysis and drug development support. The company's core products include biological microscopes capable of analyzing complex dynamic changes in numerous cells in vivo, imaging accessories, and specialized services for cellular imaging and drug kinetics. These offerings are tailored to meet the needs of medical research facilities and pharmaceutical companies seeking to enhance their in vivo analysis capabilities. IVim Technology Inc's business model centers on providing integrated solutions for cellular-level imaging and drug efficacy assessment within the healthcare sector. Revenue streams are derived from direct sales of microscopes and accessories to healthcare providers and research institutions. The company also monetizes its expertise through service-based contracts for cellular imaging acquisition and kinetic drug analysis. These services are particularly valuable for pharmaceutical firms conducting preclinical studies and developing new treatments. The firm's focus on in vivo live cell imaging technology positions it as a key supplier for advanced medical research applications. IVim Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IVim Technology stock

Free Cash Flow per Share of IVim Technology is -444.91 KRW in 2025.

Free Cash Flow per Share of IVim Technology changed from -503.46 KRW to -444.91 KRW, representing a -11.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share IVim Technology since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — IVim Technology

All Key Metrics — IVim Technology